Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system

Frontiers in Physiology

Volumn 5 JUL, Issue , 2014, Pages

  Imanaka Yoshida, Kyoko ^a,b   Aoki, Hiroki ^c  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY   (Japan)

^c KURUME UNIVERSITY   (Japan)

Author keywords

Aortic dissection; Coronary artery; Extracellular matrix; Heart; Matricellular protein; Mechanotrasduction; Tenascin C

Indexed keywords

TENASCIN;

AORTA DISSECTION; ARTICLE; DISEASE ASSOCIATION; ELASTICITY; EMBRYO DEVELOPMENT; ENDOCARDIAL CUSHION; EXTRACELLULAR MATRIX; GENE DELETION; HEART DEVELOPMENT; HEART MUSCLE CELL; HEMODYNAMIC STRESS; HUMAN; MECHANICAL STRESS; MECHANOTRANSDUCTION; MICROENVIRONMENT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TISSUE INJURY; UPREGULATION;

EID: 84904338703     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00283     Document Type: Article

References (136)

1. Wagenseil JE, Mecham RP. Vascular extracellular matrix and arterial mechanics. Physiol Rev. 2009;89:957-89. doi: 10.1152/physrev.00041.2008.
2. Caulfield JB, Borg TK. The collagen network of the heart. Lab Invest. 1979;40:364-72.
3. Borg TK, Caulfield JB. The collagen matrix of the heart. Fed Proc. 1981;40:2037-41.
4. Hinton RB, Yutzey KE. Heart valve structure and function in development and disease. Annu Rev Physiol. 2011;73:29-46. doi: 10.1146/annurev-physiol-012110-142145.
5. Sussman MA, McCulloch A, Borg TK. Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy. Circ Res. 2002;91:888-98.
6. Bowers SL, Banerjee I, Baudino TA. The extracellular matrix: at the center of it all. J Mol Cell Cardiol. 2010;48:474-82. doi: 10.1016/j.yjmcc.2009.08.024.
7. Borg TK, Baudino TA. Dynamic interactions between the cellular components of the heart and the extracellular matrix. Pflugers Arch. 2011;462:69-74. doi: 10.1007/s00424-011-0940-7.
8. Bornstein P. Matricellular proteins: an overview. J Cell Commun Signal. 2009;3:163-5. doi: 10.1007/s12079-009-0069-z.
9. Sage EH, Bornstein P. Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. J Biol Chem. 1991;266:14831-4.
10. Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol. 2002;14:608-16.
11. Conway SJ, Molkentin JD. Periostin as a heterofunctional regulator of cardiac development and disease. Curr Genomics. 2008;9:548-55. doi: 10.2174/138920208786847917.
12. Inai K, Norris RA, Hoffman S, Markwald RR, Sugi Y. BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis. Dev Biol. 2008;315:383-96. doi: 10.1016/j.ydbio.2007.12.028.
13. Norris RA, Moreno-Rodriguez RA, Sugi Y, Hoffman S, Amos J, Hart MM, Potts JD, Goodwin RL, Markwald RR. Periostin regulates atrioventricular valve maturation. Dev Biol. 2008;316:200-13. doi: 10.1016/j.ydbio.2008.01.003.
14. Norris RA, Potts JD, Yost MJ, Junor L, Brooks T, Tan H, Hoffman S, Hart MM, Kern MJ, Damon B, Markwald RR, Goodwin RL. Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev Dyn. 2009;238:1052-63. doi: 10.1002/dvdy.21933.
15. Ghatak S, Misra S, Norris RA, Moreno-Rodriguez RA, Hoffman S, Levine RA, Hascall VC, Markwald RR. Periostin Induces Intracellular Cross-talk between Kinases and Hyaluronan in Atrioventricular Valvulogenesis. J Biol Chem. 2014;289:8545-61. doi: 10.1074/jbc.M113.539882.
16. Tucker RP, Drabikowski K, Hess JF, Ferralli J, Chiquet-Ehrismann R, Adams JC. Phylogenetic analysis of the tenascin gene family: evidence of origin early in the chordate lineage. BMC Evol Biol. 2006;6:60. doi: 10.1186/1471-2148-6-60.
17. Tucker RP, Chiquet-Ehrismann R. The regulation of tenascin expression by tissue microenvironments. Biochim Biophys Acta. 2009;1793:888-92. doi: 10.1016/j.bbamcr.2008.12.012.
18. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell. 1986;47:131-9.
19. Chiquet-Ehrismann R, Tucker RP. Tenascins and the importance of adhesion modulation. Cold Spring Harb Perspect Biol. 2011;3. doi: 10.1101/cshperspect.a004960.
20. Rathjen FG, Wolff JM, Chiquet-Ehrismann R. Restrictin: a chick neural extracellular matrix protein involved in cell attachment co-purifies with the cell recognition molecule F11. Development. 1991;113:151-64.
21. Matsumoto K, Arai M, Ishihara N, Ando A, Inoko H, Ikemura T. Cluster of fibronectin type III repeats found in the human major histocompatibility complex class III region shows the highest homology with the repeats in an extracellular matrix protein, tenascin. Genomics. 1992;12:485-91.
22. Bristow J, Tee MK, Gitelman SE, Mellon SH, Miller WL. Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J Cell Biol. 1993;122:265-78.
23. Bristow J, Carey W, Egging D, Schalkwijk J. Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet. 2005;139C:24-30. doi: 10.1002/ajmg.c.30071.
24. Hagios C, Koch M, Spring J, Chiquet M, Chiquet-Ehrismann R. Tenascin-Y: a protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue. J Cell Biol. 1996;134:1499-512.
25. Weber P, Montag D, Schachner M, Bernhardt RR. Zebrafish tenascin-W, a new member of the tenascin family. J Neurobiol. 1998;35:1-16.
26. Neidhardt J, Fehr S, Kutsche M, Lohler J, Schachner M. Tenascin-N: characterization of a novel member of the tenascin family that mediates neurite repulsion from hippocampal explants. Mol Cell Neurosci. 2003;23:193-209.
27. Chiquet-Ehrismann R, Orend G, Chiquet M, Tucker RP, Midwood KS. Tenascins in stem cell niches. Matrix Biol. 2014. doi: 10.1016/j.matbio.2014.01.007.
28. Brellier F, Chiquet-Ehrismann R. How do tenascins influence the birth and life of a malignant cell? J Cell Mol Med. 2012;16:32-40. doi 10.1111/j.1582-4934.2011.01360.x.
29. Udalova IA, Ruhmann M, Thomson SJ, Midwood KS. Expression and immune function of tenascin-C. Crit Rev Immunol. 2011;31:115-45.
30. Midwood KS, Hussenet T, Langlois B, Orend G. Advances in tenascin-C biology. Cell Mol Life Sci. 2011;68:3175-99. doi: 10.1007/s00018-011-0783-6.
31. Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal. 2009;3:287-310. doi: 10.1007/s12079-009-0075-1.
32. Orend G, Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. Cancer Lett. 2006;244:143-63. doi: 10.1016/j.canlet.2006.02.017.
33. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S. Mice develop normally without tenascin. Genes Dev. 1992;6:1821-31.
34. Forsberg E, Hirsch E, Frohlich L, Meyer M, Ekblom P, Aszodi A, Werner S, Fassler R. Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc Natl Acad Sci U S A. 1996;93:6594-9.
35. Imanaka-Yoshida K. Tenascin-C in cardiovascular tissue remodeling. Circ J. 2012;76:2513-20.
36. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene. 2004;23:1656-67. doi: 10.1038/sj.onc.1207064.
37. Goh FG, Piccinini AM, Krausgruber T, Udalova IA, Midwood KS. Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J Immunol. 2010;184:2655-62. doi: 10.4049/jimmunol.0903359.
38. Mettouchi A, Cabon F, Montreau N, Dejong V, Vernier P, Gherzi R, Mercier G, Binetruy B. The c-Jun-induced transformation process involves complex regulation of tenascin-C expression. Mol Cell Biol. 1997;17:3202-9.
39. Sivasankaran B, Degen M, Ghaffari A, Hegi ME, Hamou MF, Ionescu MC, Zweifel C, Tolnay M, Wasner M, Mergenthaler S, Miserez AR, Kiss R, Lino MM, Merlo A, Chiquet-Ehrismann R, Boulay JL. Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. Cancer Res. 2009;69:458-65. doi: 10.1158/0008-5472.can-08-2610.
40. Scharer CD, McCabe CD, Ali-Seyed M, Berger MF, Bulyk ML, Moreno CS. Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res. 2009;69:709-17. doi: 10.1158/0008-5472.can-08-3415.
41. Jinnin M, Ihn H, Asano Y, Yamane K, Trojanowska M, Tamaki K. Platelet derived growth factor induced tenascin-C transcription is phosphoinositide 3-kinase/Akt-dependent and mediated by Ets family transcription factors. J Cell Physiol. 2006;206:718-27. doi: 10.1002/jcp.20527.
42. della Gaspera B, Armand AS, Sequeira I, Lecolle S, Gallien CL, Charbonnier F, Chanoine C. The Xenopus MEF2 gene family: evidence of a role for XMEF2C in larval tendon development. Dev Biol. 2009;328:392-402. doi: 10.1016/j.ydbio.2009.01.039.
43. Chiquet M, Sarasa-Renedo A, Tunc-Civelek V. Induction of tenascin-C by cyclic tensile strain versus growth factors: distinct contributions by Rho/ROCK and MAPK signaling pathways. Biochim Biophys Acta. 2004;1693:193-204. doi: 10.1016/j.bbamcr.2004.08.001.
44. Ishigaki T, Imanaka-Yoshida K, Shimojo N, Matsushima S, Taki W, Yoshida T. Tenascin-C enhances crosstalk signaling of integrin alphavbeta3/PDGFR-beta complex by SRC recruitment promoting PDGF-induced proliferation and migration in smooth muscle cells. J Cell Physiol. 2011;226:2617-24. doi: 10.1002/jcp.22614.
45. Jarvinen TA, Jozsa L, Kannus P, Jarvinen TL, Hurme T, Kvist M, Pelto-Huikko M, Kalimo H, Jarvinen M. Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle. J Cell Sci. 2003;116:857-66.
46. Jarvinen TA, Jozsa L, Kannus P, Jarvinen TL, Kvist M, Hurme T, Isola J, Kalimo H, Jarvinen M. Mechanical loading regulates tenascin-C expression in the osteotendinous junction. J Cell Sci. 1999;112:3157-66.
47. Jarvinen TA, Kannus P, Jarvinen TL, Jozsa L, Kalimo H, Jarvinen M. Tenascin-C in the pathobiology and healing process of musculoskeletal tissue injury. Scand J Med Sci Sports. 2000;10:376-82.
48. Mackie EJ, Scott-Burden T, Hahn AW, Kern F, Bernhardt J, Regenass S, Weller A, Buhler FR. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol. 1992;141:377-88.
49. Fluck M, Tunc-Civelek V, Chiquet M. Rapid and reciprocal regulation of tenascin-C and tenascin-Y expression by loading of skeletal muscle. J Cell Sci. 2000;113:3583-91.
50. Mackey AL, Brandstetter S, Schjerling P, Bojsen-Moller J, Qvortrup K, Pedersen MM, Doessing S, Kjaer M, Magnusson SP, Langberg H. Sequenced response of extracellular matrix deadhesion and fibrotic regulators after muscle damage is involved in protection against future injury in human skeletal muscle. FASEB J. 2011;25:1943-59. doi: 10.1096/fj.10-176487.
51. Mikic B, Wong M, Chiquet M, Hunziker EB. Mechanical modulation of tenascin-C and collagen-XII expression during avian synovial joint formation. J Orthop Res. 2000;18:406-15. doi: 10.1002/jor.1100180312.
52. Webb CM, Zaman G, Mosley JR, Tucker RP, Lanyon LE, Mackie EJ. Expression of tenascin-C in bones responding to mechanical load. J Bone Miner Res. 1997;12:52-8. doi: 10.1359/jbmr.1997.12.1.52.
53. Jagodzinski M, Breitbart A, Wehmeier M, Hesse E, Haasper C, Krettek C, Zeichen J, Hankemeier S. Influence of perfusion and cyclic compression on proliferation and differentiation of bone marrow stromal cells in 3-dimensional culture. J Biomech. 2008;41:1885-91. doi: 10.1016/j.jbiomech.2008.04.001.
54. Tan H, Biechler S, Junor L, Yost MJ, Dean D, Li J, Potts JD, Goodwin RL. Fluid flow forces and rhoA regulate fibrous development of the atrioventricular valves. Dev Biol. 2013;374:345-56. doi: 10.1016/j.ydbio.2012.11.023.
55. Kung C. A possible unifying principle for mechanosensation. Nature. 2005;436:647-54. doi: 10.1038/nature03896.
56. Wang N, Tytell JD, Ingber DE. Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat Rev Mol Cell Biol. 2009;10:75-82. doi: 10.1038/nrm2594.
57. Asparuhova MB, Ferralli J, Chiquet M, Chiquet-Ehrismann R. The transcriptional regulator megakaryoblastic leukemia-1 mediates serum response factor-independent activation of tenascin-C transcription by mechanical stress. FASEB J. 2011;25:3477-88. doi: 10.1096/fj.11-187310.
58. Brosig M, Ferralli J, Gelman L, Chiquet M, Chiquet-Ehrismann R. Interfering with the connection between the nucleus and the cytoskeleton affects nuclear rotation, mechanotransduction and myogenesis. Int J Biochem Cell Biol. 2010;42:1717-28. doi: 10.1016/j.biocel.2010.07.001.
59. Chiquet M, Gelman L, Lutz R, Maier S. From mechanotransduction to extracellular matrix gene expression in fibroblasts. Biochim Biophys Acta. 2009;1793:911-20. doi: 10.1016/j.bbamcr.2009.01.012.
60. Asparuhova MB, Gelman L, Chiquet M. Role of the actin cytoskeleton in tuning cellular responses to external mechanical stress. Scand J Med Sci Sports. 2009;19:490-9. doi: 10.1111/j.1600-0838.2009.00928.x.
61. Chiquet M, Tunc-Civelek V, Sarasa-Renedo A. Gene regulation by mechanotransduction in fibroblasts. Appl Physiol Nutr Metab. 2007;32:967-73. doi: 10.1139/h07-053.
62. Sarasa-Renedo A, Tunc-Civelek V, Chiquet M. Role of RhoA/ROCK-dependent actin contractility in the induction of tenascin-C by cyclic tensile strain. Exp Cell Res. 2006;312:1361-70. doi: 10.1016/j.yexcr.2005.12.025.
63. Maier S, Lutz R, Gelman L, Sarasa-Renedo A, Schenk S, Grashoff C, Chiquet M. Tenascin-C induction by cyclic strain requires integrin-linked kinase. Biochim Biophys Acta. 2008;1783:1150-62. doi: 10.1016/j.bbamcr.2008.01.013.
64. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell. 1992;70:389-99.
65. Miralles F, Posern G, Zaromytidou AI, Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell. 2003;113:329-42.
66. Guettler S, Vartiainen MK, Miralles F, Larijani B, Treisman R. RPEL motifs link the serum response factor cofactor MAL but not myocardin to Rho signaling via actin binding. Mol Cell Biol. 2008;28:732-42. doi: 10.1128/mcb.01623-07.
67. Lutz R, Sakai T, Chiquet M. Pericellular fibronectin is required for RhoA-dependent responses to cyclic strain in fibroblasts. J Cell Sci. 2010;123:1511-21. doi: 10.1242/jcs.060905.
68. Lange K, Kammerer M, Saupe F, Hegi ME, Grotegut S, Fluri E, Orend G. Combined lysophosphatidic acid/platelet-derived growth factor signaling triggers glioma cell migration in a tenascin-C microenvironment. Cancer Res. 2008;68:6942-52. doi: 10.1158/0008-5472.can-08-0347.
69. Midwood KS, Mao Y, Hsia HC, Valenick LV, Schwarzbauer JE. Modulation of cell-fibronectin matrix interactions during tissue repair. J Investig Dermatol Symp Proc. 2006;11:73-8.
70. Van Obberghen-Schilling E, Tucker RP, Saupe F, Gasser I, Cseh B, Orend G. Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth. Int J Dev Biol. 2011;55:511-25. doi: 10.1387/ijdb.103243eo.
71. Marin JL, Muniz J, Huerta M, Trujillo X. Folding-unfolding of FN-III domains in tenascin: an elastically coupled two-state system. J Biomech. 2003;36:1733-7.
72. Oberhauser AF, Marszalek PE, Erickson HP, Fernandez JM. The molecular elasticity of the extracellular matrix protein tenascin. Nature. 1998;393:181-5. doi: 10.1038/30270.
73. Lockhart M, Wirrig E, Phelps A, Wessels A. Extracellular matrix and heart development. Birth Defects Res A Clin Mol Teratol. 2011;91:535-50. doi: 10.1002/bdra.20810.
74. Imanaka-Yoshida K, Matsumoto K, Hara M, Sakakura T, Yoshida T. The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Differentiation. 2003;71:291-8.
75. Eisenberg LM, Markwald RR. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res. 1995;77:1-6.
76. Person AD, Klewer SE, Runyan RB. Cell biology of cardiac cushion development. Int Rev Cytol. 2005;243:287-335. doi: 10.1016/s0074-7696(05)43005-3.
77. Boyer AS, Erickson CP, Runyan RB. Epithelial-mesenchymal transformation in the embryonic heart is mediated through distinct pertussis toxin-sensitive and TGFbeta signal transduction mechanisms. Dev Dyn. 1999;214:81-91. doi: 10.1002/(sici)1097-0177(199901)214:1<81::aid-dvdy8>3.0.co;2-3.
78. Crossin KL, Hoffman S. Expression of adhesion molecules during the formation and differentiation of the avian endocardial cushion tissue. Dev Biol. 1991;145:277-86.
79. Zhang HY, Kluge M, Timpl R, Chu ML, Ekblom P. The extracellular matrix glycoproteins BM-90 and tenascin are expressed in the mesenchyme at sites of endothelial-mesenchymal conversion in the embryonic mouse heart. Differentiation. 1993;52:211-20.
80. Sugi Y, Markwald RR. Formation and early morphogenesis of endocardial endothelial precursor cells and the role of endoderm. Dev Biol. 1996;175:66-83. doi: 10.1006/dbio.1996.0096.
81. Hurle JM, Garcia-Martinez V, Ros MA. Immunofluorescent localization of tenascin during the morphogenesis of the outflow tract of the chick embryo heart. Anat Embryol (Berl). 1990;181:149-55.
82. Hiltgen GG, Markwald RR, Litke LL. Morphogenetic alterations during endocardial cushion development in the trisomy 16 (Down syndrome) mouse. Pediatr Cardiol. 1996;17:21-30.
83. Katoh D, Nagaharu K, Shimojo N, Hanamura N, Yamashita M, Kozuka Y, Imanaka-Yoshida K, Yoshida T. Binding of alphavbeta1 and alphavbeta6 integrins to tenascin-C induces epithelial-mesenchymal transition-like change of breast cancer cells. Oncogenesis. 2013;2:e65. doi: 10.1038/oncsis.2013.27.
84. Nagaharu K, Zhang X, Yoshida T, Katoh D, Hanamura N, Kozuka Y, Ogawa T, Shiraishi T, Imanaka-Yoshida K. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells. Am J Pathol. 2011;178:754-63. doi: 10.1016/j.ajpath.2010.10.015.
85. Garita B, Jenkins MW, Han M, Zhou C, Vanauker M, Rollins AM, Watanabe M, Fujimoto JG, Linask KK. Blood flow dynamics of one cardiac cycle and relationship to mechanotransduction and trabeculation during heart looping. Am J Physiol Heart Circ Physiol. 2011;300:H879-91. doi: 10.1152/ajpheart.00433.2010.
86. Lincoln J, Alfieri CM, Yutzey KE. Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. Dev Dyn. 2004;230:239-50. doi: 10.1002/dvdy.20051.
87. Lincoln J, Alfieri CM, Yutzey KE. BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. Dev Biol. 2006;292:290-302. doi: 10.1016/j.ydbio.2005.12.042.
88. Hinton RB, Jr., Lincoln J, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res. 2006;98:1431-8. doi: 10.1161/01.RES.0000224114.65109.4e.
89. Zhao B, Etter L, Hinton RB, Jr., Benson DW. BMP and FGF regulatory pathways in semilunar valve precursor cells. Dev Dyn. 2007;236:971-80. doi: 10.1002/dvdy.21097.
90. Lincoln J, Lange AW, Yutzey KE. Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. Dev Biol. 2006;294:292-302. doi: 10.1016/j.ydbio.2006.03.027.
91. Edom-Vovard F, Duprez D. Signals regulating tendon formation during chick embryonic development. Dev Dyn. 2004;229:449-57. doi: 10.1002/dvdy.10481.
92. Edom-Vovard F, Schuler B, Bonnin MA, Teillet MA, Duprez D. Fgf4 positively regulates scleraxis and tenascin expression in chick limb tendons. Dev Biol. 2002;247:351-66.
93. Combs MD, Yutzey KE. Heart valve development: regulatory networks in development and disease. Circ Res. 2009;105:408-21. doi: 10.1161/circresaha.109.201566.
94. Nakajima Y, Imanaka-Yoshida K. New insights into the developmental mechanisms of coronary vessels and epicardium. Int Rev Cell Mol Biol. 2013;303:263-317. doi: 10.1016/b978-0-12-407697-6.00007-6.
95. Ando K, Takahashi M, Yamagishi T, Miyagawa-Tomita S, Imanaka-Yoshida K, Yoshida T, Nakajima Y. Tenascin C may regulate the recruitment of smooth muscle cells during coronary artery development. Differentiation. 2011;81:299-306. doi: 10.1016/j.diff.2011.03.002.
96. Imanaka-Yoshida K, Miyagawa-Tomita S, Yoshida T. Tenascin-C in development and disease of blood vessels. Anat Rec (in press).
97. McCain ML, Parker KK. Mechanotransduction: the role of mechanical stress, myocyte shape, and cytoskeletal architecture on cardiac function. Pflugers Arch. 2011;462:89-104. doi: 10.1007/s00424-011-0951-4.
98. Pardo JV, Siliciano JD, Craig SW. A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements ("costameres") mark sites of attachment between myofibrils and sarcolemma. Proc Natl Acad Sci U S A. 1983;80:1008-12.
99. Pardo JV, Siliciano JD, Craig SW. Vinculin is a component of an extensive network of myofibril-sarcolemma attachment regions in cardiac muscle fibers. J Cell Biol. 1983;97:1081-8.
100. Russell B, Curtis MW, Koshman YE, Samarel AM. Mechanical stress-induced sarcomere assembly for cardiac muscle growth in length and width. J Mol Cell Cardiol. 2010;48:817-23. doi: 10.1016/j.yjmcc.2010.02.016.
101. Samarel AM. Costameres, focal adhesions, and cardiomyocyte mechanotransduction. Am J Physiol Heart Circ Physiol 2005;289:H2291-H301.
102. Danowski BA, Imanaka-Yoshida K, Sanger JM, Sanger JW. Costameres are sites of force transmission to the substratum in adult rat cardiomyocytes. J Cell Biol. 1992;118:1411-20. doi: 0.1152/ajpheart.00749.2005.
103. Imanaka-Yoshida K, Danowski BA, Sanger JM, Sanger JW. Living adult rat cardiomyocytes in culture: evidence for dissociation of costameric distribution of vinculin from costameric distributions of attachments. Cell Motil Cytoskeleton. 1996;33:263-75. doi:10.1002/(sici)1097-0169(1996)33:4<263::aid-cm3>3.0.co;2-a.
104. Imanaka-Yoshida K, Enomoto-Iwamoto M, Yoshida T, Sakakura T. Vinculin, Talin, Integrin alpha6beta1 and laminin can serve as components of attachment complex mediating contraction force transmission from cardiomyocytes to extracellular matrix. Cell Motil Cytoskeleton. 1999;42:1-11. doi: 10.1002/(sici)1097-0169(1999)42:1<1::aid-cm1>3.0.co;2-0.
105. Imanaka-Yoshida K, Hiroe M, Yoshida T. Interaction between cell and extracellular matrix in heart disease: multiple roles of tenascin-C in tissue remodeling. Histol Histopathol. 2004;19:517-25.
106. Okamoto H, Imanaka-Yoshida K. Matricellular proteins: new molecular targets to prevent heart failure. Cardiovasc Ther. 2012;30:e198-209. doi: 10.1111/j.1755-5922.2011.00276.x.
107. Imanaka-Yoshida K, Hiroe M, Nishikawa T, Ishiyama S, Shimojo T, Ohta Y, Sakakura T, Yoshida T. Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction. Lab Invest. 2001;81:1015-24.
108. Nishioka T, Onishi K, Shimojo N, Nagano Y, Matsusaka H, Ikeuchi M, Ide T, Tsutsui H, Hiroe M, Yoshida T, Imanaka-Yoshida K. Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice. Am J Physiol Heart Circ Physiol. 2010;298:H1072-8. doi. 10.1152/ajpheart.00255.2009.
109. Kimura T, Shiraishi K, Furusho A, Ito S, Hirakata S, Nishida N, Yoshimura K, Imanaka-Yoshida K, Yoshida T, Ikeda Y, Miyamoto T, Ueno T, Hamano K, Hiroe M, Aonuma K, Matsuzaki M, Imaizumi T, Aoki H. Tenascin C protects aorta from acute dissection in mice. Scientific Reports. 2014. doi 10.1038/srep04051.
110. Agabiti-Rosei E, Mancia G, O'Rourke MF, Roman MJ, Safar ME, Smulyan H, Wang JG, Wilkinson IB, Williams B, Vlachopoulos C. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension. 2007;50:154-60. doi: 10.1161/hypertensionaha.107.090068.
111. Cronenwett JL, Johnston W. Rutherford's Vascular Surgery. 7th ed. Philadelphia: Saunders; 2010.
112. Jondeau G, Boutouyrie P, Lacolley P, Laloux B, Dubourg O, Bourdarias JP, Laurent S. Central pulse pressure is a major determinant of ascending aorta dilation in Marfan syndrome. Circulation. 1999;99:2677-81.
113. Kumar MS, Owens GK. Combinatorial control of smooth muscle-specific gene expression. Arteriosclerosis, thrombosis, and vascular biology. 2003;23:737-47. doi: 10.1161/01.ATV.0000065197.07635.BA.
114. Bobik A. Transforming growth factor-betas and vascular disorders. Arteriosclerosis, thrombosis, and vascular biology. 2006;26:1712-20. doi: 10.1161/01.ATV.0000225287.20034.2c.
115. Wang Y, Ait-Oufella H, Herbin O, Bonnin P, Ramkhelawon B, Taleb S, Huang J, Offenstadt G, Combadiere C, Renia L, Johnson JL, Tharaux PL, Tedgui A, Mallat Z. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest. 2010;120:422-32. doi: 10.1172/JCI38136.
116. Dai J, Losy F, Guinault AM, Pages C, Anegon I, Desgranges P, Becquemin JP, Allaire E. Overexpression of transforming growth factor-beta1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Circulation. 2005;112:1008-15. doi: 10.1161/CIRCULATIONAHA.104.523357.
117. Dietz HC. TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions. J Clin Invest. 2010;120:403-7. doi: 10.1172/jci42014.
118. Nozato T, Sato A, Hirose S, Hikita H, Takahashi A, Endo H, Imanaka-Yoshida K, Yoshida T, Aonuma K, Hiroe M. Preliminary study of serum tenascin-C levels as a diagnostic or prognostic biomarker of type B acute aortic dissection. International journal of cardiology. 2013;168:4267-9. doi: 10.1016/j.ijcard.2013.04.211.
119. Trescher K, Thometich B, Demyanets S, Kassal H, Sedivy R, Bittner R, Holzinger C, Podesser BK. Type A dissection and chronic dilatation: tenascin-C as a key factor in destabilization of the aortic wall. Interactive cardiovascular and thoracic surgery. 2013;17:365-70. doi: 10.1093/icvts/ivt204.
120. Wang JH, Thampatty BP. Mechanobiology of adult and stem cells. Int Rev Cell Mol Biol. 2008;271:301-46. doi: 10.1016/s1937-6448(08)01207-0.
121. Yang R, Amir J, Liu H, Chaqour B. Mechanical strain activates a program of genes functionally involved in paracrine signaling of angiogenesis. Physiol Genomics. 2008;36:1-14. doi: 10.1152/physiolgenomics.90291.2008.
122. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, Drexler S, Sofat N, Kashiwagi M, Orend G, Brennan F, Foxwell B. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med. 2009;15:774-80. doi: 10.1038/nm.1987.
123. Hanna M, Liu H, Amir J, Sun Y, Morris SW, Siddiqui MA, Lau LF, Chaqour B. Mechanical regulation of the proangiogenic factor CCN1/CYR61 gene requires the combined activities of MRTF-A and CREB-binding protein histone acetyltransferase. J Biol Chem. 2009;284:23125-36. doi: 10.1074/jbc.M109.019059.
124. Schild C, Trueb B. Three members of the connective tissue growth factor family CCN are differentially regulated by mechanical stress. Biochim Biophys Acta. 2004;1691:33-40. doi: 10.1016/j.bbamcr.2003.12.001.
125. Chaqour B, Yang R, Sha Q. Mechanical stretch modulates the promoter activity of the profibrotic factor CCN2 through increased actin polymerization and NF-kappaB activation. J Biol Chem. 2006;281:20608-22. doi: 10.1074/jbc.M600214200.
126. Honjo T, Kubota S, Kamioka H, Sugawara Y, Ishihara Y, Yamashiro T, Takigawa M, Takano-Yamamoto T. Promotion of Ccn2 expression and osteoblastic differentiation by actin polymerization, which is induced by laminar fluid flow stress. J Cell Commun Signal. 2012;6:225-32. doi: 10.1007/s12079-012-0177-z.
127. Endlich N, Sunohara M, Nietfeld W, Wolski EW, Schiwek D, Kranzlin B, Gretz N, Kriz W, Eickhoff H, Endlich K. Analysis of differential gene expression in stretched podocytes: osteopontin enhances adaptation of podocytes to mechanical stress. FASEB J. 2002;16:1850-2. doi: 10.1096/fj.02-0125fje.
128. Ussher JR, Koves TR, Jaswal JS, Zhang L, Ilkayeva O, Dyck JR, Muoio DM, Lopaschuk GD. (2009). Insulin stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase. Diabetes 58, 1766-75.
129. van Loon LJ, Greenhaff PL, Constantin-Teodosiu D, Saris WH, Wagenmakers AJ. (2001). The effects of increasing exercise intensity on muscle fuel utilisation in humans. J Physiol 536:295-304.
130. van Loon LJ, Koopman R, Stegen JH, Wagenmakers AJ, Keizer HA, Saris WH. (2003). Intramyocellular lipids form an important substrate source during moderate intensity exercise in endurance-trained males in a fasted state. J Physiol 553:611-25.
131. Wallace DC. (2012). Mitochondria and cancer. Nat Rev Cancer 12:685-98.
132. Walther TC, Farese RV, Jr. (2009). The life of lipid droplets. Biochim Biophys Acta 1791:459-66.
133. Durvasula RV, Shankland SJ. Mechanical strain increases SPARC levels in podocytes: implications for glomerulosclerosis. Am J Physiol Renal Physiol. 2005;289:F577-84. doi: 10.1152/ajprenal.00393.2004.
134. Yamashita O, Yoshimura K, Nagasawa A, Ueda K, Morikage N, Ikeda Y, Hamano K. Periostin links mechanical strain to inflammation in abdominal aortic aneurysm. PLoS One. 2013;8:e79753. doi: 10.1371/journal.pone.0079753.
135. Suzuki H, Shiba M, Fujimoto M, Kawamura K, Nanpei M, Tekeuchi E, Matsushima S, Kanamaru K, Imanaka-Yoshida K, Yoshida T, Taki W. Matricellular protein: a new player in cerebral vasospasm following subarachnoid hemorrhage. Acta Neurochir Suppl. 2013;115:213-8. doi: 10.1007/978-3-7091-1192-5_39.
136. Kii I, Nishiyama T, Li M, Matsumoto K, Saito M, Amizuka N, Kudo A. Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem. 2010;285:2028-39. doi: 10.1074/jbc.M109.051961.